Continuous Glucose Monitoring Systems Market Research Report Information by Product (Sensors, And Transmitter and Receivers), By Application (Type 2, Type 1, Non-diabetic Patients), By End User (Hospitals & Clinics, Homecare Settings, And Others), by Region (North America, Europe, Asia-Pacific, and Rest of the World) - Forecast till 2032

TABLE OF CONTENTS

2 MARKET INTRODUCTION

2.1 DEFINITION

2.2 SCOPE OF THE STUDY

2.3 RESEARCH OBJECTIVE

2.4 MARKET STRUCTURE

3 RESEARCH METHODOLOGY

3.1 OVERVIEW

3.2 DATA FLOW

3.2.1 DATA MINING PROCESS

3.3 PURCHASED DATABASE:

3.4 SECONDARY SOURCES:

3.4.1 SECONDARY RESEARCH DATA FLOW:

3.5 PRIMARY RESEARCH:

3.5.1 PRIMARY RESEARCH DATA FLOW:

3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED

3.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE

3.6 APPROACHES FOR MARKET SIZE ESTIMATION:

3.6.1 REVENUE ANALYSIS APPROACH

3.7 DATA FORECASTING

3.7.1 DATA FORECASTING TECHNIQUE

3.8 DATA MODELING

3.8.1 MICROECONOMIC FACTOR ANALYSIS:

3.8.2 DATA MODELING:

3.9 TEAMS AND ANALYST CONTRIBUTION

4 MARKET DYNAMICS

4.1 INTRODUCTION

4.2 DRIVERS

4.2.1 INCREASING PREVALENCE OF DIABETES

4.2.2 RISING AWARENESS AMONG INDIVIDUALS ABOUT THE BENEFITS OF CONTINUOUS GLUCOSE MONITORING AND PATIENT EDUCATION

4.2.3 INCREASING GERIATRIC POPULATION

4.3 RESTRAINTS

4.3.1 HIGH COST OF CONTINUOUS GLUCOSE MONITORING SYSTEMS

4.4 OPPORTUNITY

4.4.1 GROWING TECHNOLOGICAL ADVANCEMENTS AND INNOVATION

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS

5.1.1 R&D

5.1.2 MANUFACTURING

5.1.3 DISTRIBUTION AND SALES

5.1.4 POST-SALES MONITORING

5.2 PORTER’S FIVE FORCES MODEL

5.2.1 THREAT OF NEW ENTRANTS

5.2.2 BARGAINING POWER OF SUPPLIERS

5.2.3 THREAT OF SUBSTITUTES

5.2.4 BARGAINING POWER OF BUYERS

5.2.5 INTENSITY OF RIVALRY

5.3 IMPACT OF COVID-19 ON THE GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET

5.3.1 OVERVIEW

6 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT

6.1 OVERVIEW

6.2 SENSORS

6.3 TRANSMITTER & RECEIVERS

7 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION

7.1 OVERVIEW

7.2 TYPE 2 DIABETES

7.3 TYPE 1 DIABETES

7.4 NON-DIABETIC PATIENTS

7.4.1 WEIGHT LOSS

7.4.2 DIET MANAGEMENT

7.4.3 HEALTH & WELLNESS

8 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER

8.1 OVERVIEW

8.2 HOSPITALS & CLINICS

8.3 HOMECARE SETTINGS

8.4 OTHERS

9 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION

9.1 GLOBAL

9.2 NORTH AMERICA

9.2.1 US

9.2.2 CANADA

9.3 EUROPE

9.3.1 GERMANY

9.3.2 FRANCE

9.3.3 UK

9.3.4 ITALY

9.3.5 SPAIN

9.3.6 REST OF EUROPE

9.4 ASIA-PACIFIC

9.4.1 CHINA

9.4.2 INDIA

9.4.3 JAPAN

9.4.4 SOUTH KOREA

9.4.5 AUSTRALIA

9.4.6 REST OF ASIA-PACIFIC

9.5 REST OF THE WORLD

9.5.1 MIDDLE EAST & AFRICA

9.5.2 LATIN AMERICA

10 COMPETITIVE LANDSCAPE

10.1 INTRODUCTION

10.2 MARKET SHARE ANALYSIS, 2023

10.3 COMPETITOR DASHBOARD

10.4 PUBLIC PLAYERS STOCK SUMMARY

10.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL

10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES

10.6.1 PRODUCT LAUNCH/PRODUCT APPROVAL

10.6.2 AGREEMENT

10.6.3 PARTNERSHIP

10.6.4 COLLABORATION

11 COMPANY PROFILES

11.1 DEXCOM, INC

11.1.1 COMPANY OVERVIEW

11.1.2 FINANCIAL OVERVIEW

11.1.3 PRODUCTS OFFERED

11.1.4 KEY DEVELOPMENTS

11.1.5 SWOT ANALYSIS

11.1.6 KEY STRATEGIES

11.2 A. MENARINI DIAGNOSTICS SRL

11.2.1 COMPANY OVERVIEW

11.2.2 FINANCIAL OVERVIEW

11.2.3 PRODUCTS OFFERED

11.2.4 KEY DEVELOPMENTS

11.2.5 KEY STRATEGIES

11.3 SENSEONICS

11.3.1 COMPANY OVERVIEW

11.3.2 FINANCIAL OVERVIEW

11.3.3 PRODUCTS OFFERED

11.3.4 KEY DEVELOPMENTS

11.3.5 KEY STRATEGIES

11.4 MEDTRUM TECHNOLOGIES INC.

11.4.1 COMPANY OVERVIEW

11.4.2 FINANCIAL OVERVIEW

11.4.3 PRODUCTS OFFERED

11.4.4 KEY DEVELOPMENTS

11.4.5 KEY STRATEGIES

11.5 NEMAURA MEDICAL INC.

11.5.1 COMPANY OVERVIEW

11.5.2 FINANCIAL OVERVIEW

11.5.3 PRODUCTS OFFERED

11.5.4 KEY DEVELOPMENTS

11.5.5 SWOT ANALYSIS

11.5.6 KEY STRATEGIES

11.6 ULTRAHUMAN HEALTHCARE PVT LTD

11.6.1 COMPANY OVERVIEW

11.6.2 FINANCIAL OVERVIEW

11.6.3 PRODUCTS OFFERED

11.6.4 KEY DEVELOPMENTS

11.6.5 KEY STRATEGIES

11.7 MEDTRONIC

11.7.1 COMPANY OVERVIEW

11.7.2 FINANCIAL OVERVIEW

11.7.3 PRODUCTS OFFERED

11.7.4 KEY DEVELOPMENTS

11.7.5 SWOT ANALYSIS

11.7.6 KEY STRATEGIES

11.8 ONE DROP

11.8.1 COMPANY OVERVIEW

11.8.2 FINANCIAL OVERVIEW

11.8.3 PRODUCTS OFFERED

11.8.4 KEY DEVELOPMENTS

11.8.5 SWOT ANALYSIS

11.8.6 KEY STRATEGIES

11.9 ABBOTT LABORATORIES, INC.

11.9.1 COMPANY OVERVIEW

11.9.2 FINANCIAL OVERVIEW

11.9.3 PRODUCTS OFFERED

11.9.4 KEY DEVELOPMENTS

11.9.5 SWOT ANALYSIS

11.9.6 KEY STRATEGIES

11.10 SINOCARE

11.10.1 COMPANY OVERVIEW

11.10.2 FINANCIAL OVERVIEW

11.10.3 PRODUCTS OFFERED

11.10.4 KEY DEVELOPMENTS

11.10.5 KEY STRATEGIES

11.11 NUTRISENSE

11.11.1 COMPANY OVERVIEW

11.11.2 FINANCIAL OVERVIEW

11.11.3 PRODUCTS OFFERED

11.11.4 KEY DEVELOPMENTS

11.11.5 KEY STRATEGIES

11.12 SUPERSAPIENS

11.12.1 COMPANY OVERVIEW

11.12.2 FINANCIAL OVERVIEW

11.12.3 PRODUCTS OFFERED

11.12.4 KEY DEVELOPMENTS

11.12.5 KEY STRATEGIES

11.13 SIGNOS INC.

11.13.1 COMPANY OVERVIEW

11.13.2 FINANCIAL OVERVIEW

11.13.3 PRODUCTS OFFERED

11.13.4 KEY DEVELOPMENTS

11.13.5 KEY STRATEGIES

11.14 LEVELS

11.14.1 COMPANY OVERVIEW

11.14.2 FINANCIAL OVERVIEW

11.14.3 PRODUCTS OFFERED

11.14.4 KEY DEVELOPMENTS

11.14.5 KEY STRATEGIES

11.15 VERI

11.15.1 COMPANY OVERVIEW

11.15.2 FINANCIAL OVERVIEW

11.15.3 PRODUCTS OFFERED

11.15.4 KEY DEVELOPMENTS

11.15.5 KEY STRATEGIES

11.16 LUMEN

11.16.1 COMPANY OVERVIEW

11.16.2 FINANCIAL OVERVIEW

11.16.3 PRODUCTS OFFERED

11.16.4 KEY DEVELOPMENTS

11.16.5 KEY STRATEGIES

11.17 JANUARY.AI

11.17.1 COMPANY OVERVIEW

11.17.2 FINANCIAL OVERVIEW

11.17.3 PRODUCTS OFFERED

11.17.4 KEY DEVELOPMENTS

11.17.5 KEY STRATEGIES

12 DATA CITATIONS

LIST OF TABLES

TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT

TABLE 2 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019–2032 (USD MILLION)

TABLE 3 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR SENSORS, BY REGION, 2019–2032 (USD MILLION)

TABLE 4 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR TRANSMITTER & RECEIVERS, BY REGION, 2019–2032 (USD MILLION)

TABLE 5 GLOBAL: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 6 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR TYPE 2 DIABETES, BY REGION, 2019–2032 (USD MILLION)

TABLE 7 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR TYPE 2 DIABETES, BY REGION, 2019–2032 (USD MILLION)

TABLE 8 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR NON-DIABETIC PATIENTS, BY REGION, 2019–2032 (USD MILLION)

TABLE 9 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR NON-DIABETIC PATIENTS, BY TYPE, 2019–2032 (USD MILLION)

TABLE 10 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR WEIGHT LOSS, BY REGION, 2019–2032 (USD MILLION)

TABLE 11 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR DIET MANAGEMENT, BY REGION, 2019–2032 (USD MILLION)

TABLE 12 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET HEALTH & WELLNESS, BY REGION, 2019–2032 (USD MILLION)

TABLE 13 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 14 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR HOSPITALS & CLINICS, BY REGION, 2019–2032 (USD MILLION)

TABLE 15 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR HOMECARE SETTINGS, BY REGION, 2019–2032 (USD MILLION)

TABLE 16 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR OTHERS, BY REGION, 2019–2032 (USD MILLION)

TABLE 17 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION, 2019–2032 (USD MILLION)

TABLE 18 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2019–2032 (USD MILLION)

TABLE 19 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019–2032 (USD MILLION)

TABLE 20 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 21 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019–2032 (USD MILLION)

TABLE 22 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 23 US: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019–2032 (USD MILLION)

TABLE 24 US: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 25 US: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019–2032 (USD MILLION)

TABLE 26 US: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 27 CANADA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019–2032 (USD MILLION)

TABLE 28 CANADA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 29 CANADA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019–2032 (USD MILLION)

TABLE 30 CANADA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 31 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2019–2032 (USD MILLION)

TABLE 32 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019–2032 (USD MILLION)

TABLE 33 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 34 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019–2032 (USD MILLION)

TABLE 35 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 36 GERMANY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019–2032 (USD MILLION)

TABLE 37 GERMANY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 38 GERMANY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019–2032 (USD MILLION)

TABLE 39 GERMANY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 40 FRANCE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019–2032 (USD MILLION)

TABLE 41 FRANCE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 42 FRANCE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019–2032 (USD MILLION)

TABLE 43 FRANCE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 44 UK: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019–2032 (USD MILLION)

TABLE 45 UK: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 46 UK: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019–2032 (USD MILLION)

TABLE 47 UK: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 48 ITALY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019–2032 (USD MILLION)

TABLE 49 ITALY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 50 ITALY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019–2032 (USD MILLION)

TABLE 51 ITALY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 52 SPAIN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019–2032 (USD MILLION)

TABLE 53 SPAIN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 54 SPAIN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019–2032 (USD MILLION)

TABLE 55 SPAIN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 56 REST OF EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019–2032 (USD MILLION)

TABLE 57 REST OF EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 58 REST OF EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019–2032 (USD MILLION)

TABLE 59 REST OF EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 60 ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2019–2032 (USD MILLION)

TABLE 61 ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019–2032 (USD MILLION)

TABLE 62 ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 63 ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019–2032 (USD MILLION)

TABLE 64 ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019–2032 (USD MILLION)

TABLE 65 CHINA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019–2032 (USD MILLION)

TABLE 66 CHINA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 67 CHINA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019–2032 (USD MILLION)

TABLE 68 CHINA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019–2032 (USD MILLION)

TABLE 69 INDIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019–2032 (USD MILLION)

TABLE 70 INDIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 71 INDIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019–2032 (USD MILLION)

TABLE 72 INDIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019–2032 (USD MILLION)

TABLE 73 JAPAN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019–2032 (USD MILLION)

TABLE 74 JAPAN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 75 JAPAN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019–2032 (USD MILLION)

TABLE 76 JAPAN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019–2032 (USD MILLION)

TABLE 77 SOUTH KOREA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019–2032 (USD MILLION)

TABLE 78 SOUTH KOREA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 79 SOUTH KOREA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019–2032 (USD MILLION)

TABLE 80 SOUTH KOREA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019–2032 (USD MILLION)

TABLE 81 AUSTRALIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019–2032 (USD MILLION)

TABLE 82 AUSTRALIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 83 AUSTRALIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019–2032 (USD MILLION)

TABLE 84 AUSTRALIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019–2032 (USD MILLION)

TABLE 85 REST OF ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019–2032 (USD MILLION)

TABLE 86 REST OF ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 87 REST OF ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019–2032 (USD MILLION)

TABLE 88 REST OF ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019–2032 (USD MILLION)

TABLE 89 REST OT THE WORLD: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION, 2019–2032 (USD MILLION)

TABLE 90 REST OF THE WORLD: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019–2032 (USD MILLION)

TABLE 91 REST OF THE WORLD: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 92 REST OF THE WORLD: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019–2032 (USD MILLION)

TABLE 93 REST OF THE WORLD: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019–2032 (USD MILLION)

TABLE 94 MIDDLE EAST & AFRICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019–2032 (USD MILLION)

TABLE 95 MIDDLE EAST & AFRICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 96 MIDDLE EAST & AFRICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019–2032 (USD MILLION)

TABLE 97 MIDDLE EAST & AFRICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019–2032 (USD MILLION)

TABLE 98 LATIN AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019–2032 (USD MILLION)

TABLE 99 LATIN AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 100 LATIN AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019–2032 (USD MILLION)

TABLE 101 LATIN AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019–2032 (USD MILLION)

TABLE 102 PUBLIC PLAYERS STOCK SUMMARY

TABLE 103 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL

TABLE 104 PRODUCT LAUNCH/PRODUCT APPROVAL

TABLE 105 AGREEMENT

TABLE 106 PERTNERSHIP

TABLE 107 COLLABORATION

TABLE 108 DEXCOM, INC: PRODUCT OFFERED

TABLE 109 DEXCOM, INC: KEY DEVELOPMENTS

TABLE 110 A. MENARINI DIAGNOSTICS SRL: PRODUCT OFFERED

TABLE 111 A. MENARINI DIAGNOSTICS SRL: KEY DEVELOPMENTS

TABLE 112 SENSEONICS: PRODUCT OFFERED

TABLE 113 SENSEONICS: KEY DEVELOPMENTS

TABLE 114 MEDTRUM TECHNOLOGIES INC.: PRODUCTS OFFERED

TABLE 115 NEMAURA MEDICAL INC.: PRODUCTS OFFERED

TABLE 116 NEMAURA MEDICAL INC.: KEY DEVELOPMENTS

TABLE 117 ULTRAHUMAN HEALTHCARE PVT LTD.: PRODCUTS OFFERED

TABLE 118 MEDTRONIC: PRODUCTS OFFERED

TABLE 119 MEDTRONIC: KEY DEVELOPMENTS

TABLE 120 ONE DROP: PRODUCTS OFFERED

TABLE 121 ABBOTT LABORATORIES, INC.: PRODUCTS OFFERED

TABLE 122 ABBOTT LABORATORIES, INC.: KEY DEVELOPMENTS

TABLE 123 SINOCARE: PRODUCTS OFFERED

TABLE 124 NUTRISENSE: PRODUCTS OFFERED

TABLE 125 NEMAURA MEDICAL INC.: PRODUCTS OFFERED

TABLE 126 SIGNOS INC.: PRODUCTS OFFERED

TABLE 127 LEVELS: PRODUCTS OFFERED

TABLE 128 VERI: PRODUCTS OFFERED

TABLE 129 LUMEN: PRODUCTS OFFERED

TABLE 130 JANUARY.AI: PRODUCTS OFFERED

LIST OF FIGURES

FIGURE 1 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET: STRUCTURE

FIGURE 2 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET: MARKET GROWTH FACTOR ANALYSIS (2023-2032)

FIGURE 3 DRIVER IMPACT ANALYSIS (2024-2032)

FIGURE 4 RESTRAINT IMPACT ANALYSIS (2023-2032)

FIGURE 5 VALUE CHAIN ANALYSIS OF THE GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET

FIGURE 6 PORTER’S FIVE FORCES ANALYSIS: GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET

FIGURE 7 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2023 & 2032 (USD MILLION)

FIGURE 8 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, SHARE (%), BY PRODUCT, 2023

FIGURE 9 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2023 & 2032 (USD MILLION)

FIGURE 10 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, SHARE (%), BY APPLICATION, 2023

FIGURE 11 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2023 & 2032 (USD MILLION)

FIGURE 12 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, SHARE (%), BY END USER, 2023

FIGURE 13 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SHARE, BY REGION, 2023 (% SHARE)

FIGURE 14 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION, 2023 & 2032 (USD MILLION)

FIGURE 15 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SHARE, BY COUNTRY, 2023 (% SHARE)

FIGURE 16 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION)

FIGURE 17 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SHARE, BY COUNTRY, 2023 (% SHARE)

FIGURE 18 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION)

FIGURE 19 ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION)

FIGURE 20 ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SHARE (%), BY COUNTRY, 2023

FIGURE 21 REST OT THE WORLD: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION, 2023 & 2032 (USD MILLION)

FIGURE 22 REST OT THE WORLD: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SHARE (%), BY REGION, 2023

FIGURE 23 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET PLAYERS: COMPETITIVE ANALSIS, 2023

FIGURE 24 COMPETITOR DASHBOARD: GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET

FIGURE 25 DEXCOM, INC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 26 DEXCOM, INC: SWOT ANALYSIS

FIGURE 27 SENSEONICS: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 28 NEMAURA MEDICAL INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 29 NEMAURA MEDICAL INC.: SWOT ANALYSIS

FIGURE 30 MEDTRONIC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 31 MEDTRONIC: SWOT ANALYSIS

FIGURE 32 ONE DROP: SWOT ANALYSIS

FIGURE 33 ABBOTT LABORATORIES, INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 34 ABBOTT LABORATORIES INC.: SWOT ANALYSIS

LIST OF FIGURES

FIGURE 1 GLOBAL DIGITAL HEALTH MARKET: STRUCTURE

FIGURE 2 GLOBAL DIGITAL HEALTH MARKET: MARKET GROWTH FACTOR ANALYSIS (2024-2032)

FIGURE 3 DRIVER IMPACT ANALYSIS (2024-2032)

FIGURE 4 RESTRAINT IMPACT ANALYSIS (2024-2032)

FIGURE 5 VALUE CHAIN ANALYSIS OF THE GLOBAL DIGITAL HEALTH MARKET

FIGURE 6 PORTER’S FIVE FORCES ANALYSIS: GLOBAL DIGITAL HEALTH MARKET

FIGURE 7 GLOBAL DIGITAL HEALTH MARKET, BY TECHNOLOGY, SEGMENT ATTRACTIVENESS, 2024-2032 (USD MILLION)

FIGURE 8 GLOBAL DIGITAL HEALTH MARKET, BY TECHNOLOGY, 2023 & 2032 (USD MILLION)

FIGURE 9 GLOBAL DIGITAL HEALTH MARKET SHARE (%), BY TECHNOLOGY, 2023

FIGURE 10 GLOBAL DIGITAL HEALTH MARKET, BY COMPONENT, SEGMENT ATTRACTIVENESS, 2024-2032 (USD MILLION)

FIGURE 11 GLOBAL DIGITAL HEALTH MARKET, BY COMPONENT, 2023 & 2032 (USD MILLION)

FIGURE 12 GLOBAL DIGITAL HEALTH MARKET SHARE (%), BY COMPONENT, 2023

FIGURE 13 GLOBAL DIGITAL HEALTH MARKET, APPLICATION SEGMENT ATTRACTIVENESS, 2023 & 2032 (USD MILLION)

FIGURE 14 GLOBAL DIGITAL HEALTH MARKET, END USER SEGMENT ATTRACTIVENESS, 2023 & 2032 (USD MILLION)

FIGURE 15 GLOBAL DIGITAL HEALTH MARKET, BY END USER, 2023 & 2032 (USD MILLION)

FIGURE 16 GLOBAL DIGITAL HEALTH MARKET SHARE (%), BY END USER, 2023

FIGURE 17 GLOBAL DIGITAL HEALTH MARKET SHARE, BY REGION, 2023 (% SHARE)

FIGURE 18 GLOBAL DIGITAL HEALTH MARKET, BY REGION, 2023 AND 2032 (USD MILLION)

FIGURE 19 NORTH AMERICA MARKET ANALYSIS: DIGITAL HEALTH MARKET, 2018-2032 (USD MILLION)

FIGURE 20 NORTH AMERICA: DIGITAL HEALTH MARKET SHARE, BY COUNTRY, 2023 (% SHARE)

FIGURE 21 NORTH AMERICA: DIGITAL HEALTH MARKET, BY COUNTRY, 2023 & 20232 (USD MILLION)

FIGURE 22 EUROPE MARKET ANALYSIS: DIGITAL HEALTH MARKET, 2018-2032 (USD MILLION)

FIGURE 23 EUROPE: DIGITAL HEALTH MARKET SHARE, BY COUNTRY, 2023 (% SHARE)

FIGURE 24 EUROPE: DIGITAL HEALTH MARKET, BY COUNTRY, 2023 AND 2032 (USD MILLION)

FIGURE 25 ASIA-PAIFIC MARKET ANALYSIS: DIGITAL HEALTH MARKET, 2018-2032 (USD MILLION)

FIGURE 26 ASIA-PAIFIC: DIGITAL HEALTH MARKET SHARE, BY COUNTRY, 2023 (% SHARE)

FIGURE 27 ASIA-PAIFIC: DIGITAL HEALTH MARKET, BY COUNTRY, 2023 AND 2032 (USD MILLION)

FIGURE 28 REST OF THE WORLD MARKET ANALYSIS: DIGITAL HEALTH MARKET, 2018-2032 (USD MILLION)

FIGURE 29 REST OF THE WORLD: DIGITAL HEALTH MARKET SHARE, BY COUNTRY, 2023 (% SHARE)

FIGURE 30 REST OF THE WORLD: DIGITAL HEALTH MARKET, BY COUNTRY, 2023 AND 2032 (USD MILLION)

FIGURE 31 GLOBAL DIGITAL HEALTH MARKET PLAYERS: COMPETITIVE ANALSIS, 2023

FIGURE 32 COMPETITOR DASHBOARD: GLOBAL DIGITAL HEALTH MARKET

FIGURE 33 KONINKLIJKE PHILIPS N.V.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 34 ATHENAHEALTH: SWOT ANALYSIS

FIGURE 35 CISCO SYSTEMS, INC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 36 EPIC SYSTEMS CORPORATION: SWOT ANALYSIS

FIGURE 37 NXGN MANAGEMENT, LLC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 38 NXGN MANAGEMENT, LLC: SWOT ANALYSIS

FIGURE 39 MCKESSON CORPORATION: FINANCIAL OVERVIEW

FIGURE 40 GENERAL ELECTRIC COMPANY: SWOT ANALYSIS

FIGURE 41 GENERAL ELECTRIC COMPANY: FINANCIAL OVERVIEW

FIGURE 42 GENERAL ELECTRIC COMPANY: SWOT ANALYSIS

FIGURE 43 VERADIGM, LLC: FINANCIAL OVERVIEW SNAPSHOT